- FDA finds rare neurological disorder ‘potential risk’ with Pfizer RSV vaccineThe old times
- Rare neurological disease is ‘significant potential risk’ of Pfizer’s RSV vaccine, FDA saysIndianapolis, IN
- FDA warns of Guillain-Barré syndrome as possible risk from Pfizer’s RSV vaccineNew York Daily News
- FDA finds rare neurological disorder ‘potential risk’ with Pfizer RSV vaccineMTN
- Pfizer/BioNTech Seeks Expanded Approval for Updated COVID-19 Vaccine as Primary Series VaccinationYahoo finance
- See full coverage on Google News